Credits: Ian Haydon (Institute for Protein Design)

Unlocking the power of nanopores

Poking holes through membranes with atomic accuracy to build pocket-sized ‘molecule detectives’

Brussels/Washington 19/07/2024 - Transmembrane β-barrel pores (TMBs) are extensively used for single-molecule DNA and RNA sequencing. They enable the miniaturization of a wide array of sensing and sequencing applications into portable USB-size devices and point-of-care technologies. A team of Belgian and American researchers has now described a general approach to design TMB pores from scratch with custom shapes and properties, opening up new opportunities for single-molecule analytics. Their results were published in Science.

Rolling out new barrels …

Protein nanopores are the holy grail in the field of analytical biology. These nanometer-sized proteins form regular pores in lipid membranes and are widely used for single-molecule DNA and RNA sequencing. They hold a considerable potential to advance a broad range of sensing and sequencing applications by taking them out of specialized labs and into portable devices. However, current approaches to engineering nanopore sensors are limited to naturally occurring proteins, which have evolved for very different functions and are less than ideal starting points for sensor development.

Research led by the VIB-VUB Center for Structural Biology (Belgium) and the University of Washington School of Medicine (USA) has taken on the challenge of designing these protein ‘barrels’ from scratch, with the ultimate goal of controlling the shape and chemistry on a molecular level. With the help of computational design, the researchers developed methods to design stable nanopore channels with tunable pore shapes, sizes, and conductance. Compared to natural pores, the signal generated by the designed TMBs was remarkably stable and quiet. Collaborators in the laboratory of Sheena Radford (University of Leeds) and Sebastian Hiller (Biozentrum, University of Basel) found that the designs folded into stable 3D structures. This opens the door to designing nanopore channels de novo that are suitable for many applications of interest in research and industry.

“These developments are very exciting. When we started with this idea a few years ago, many people thought it was impossible, because the design and folding of β-sheets is incredibly complex, let alone in lipid membranes. Now we have shown that we can successfully design nanopores with a high success rate, which have stable and reproducible conductance.” - Dr. Anastassia Vorobieva, group leader at the VIB-VUB Center for Structural Biology.
Professor Anastassia Vorobieva, VIB-VUB Center for Structural Biology

… and putting them to good use

As the next step, the researchers put their design method to the test. Nanopores that can detect very small molecules such as metabolites would be extremely useful tools for metabolomic and diagnostic analysis, which currently require large, specialized lab equipment. The design of functional small-molecule sensors remains challenging because of the complexity of protein-ligand interactions. Hence, the pores need to have a highly complementary shape to the small molecule of interest. A team from the laboratory of UW Medicine biochemistry professor and HHMI Investigator David Baker successfully designed new proteins that can specifically bind small-molecule metabolites. They split the proteins into three parts and fused the parts into the loops of a TMB pore. They found that they could directly detect single-molecule binding events using such constructs.

“This collaboration is a great example of what's possible with protein design. Rather than repurposing biomolecules from nature, we can now create the functions we want from first principles." – Prof. Dr. David Baker, professor at the University of Washington School of Medicine and HHMI investigator.

The positive results prove that nanopore design can complement mass spectrometry and other analytical methods that require big labs and big setups because the technology is smaller and more accessible. Although we are still quite a bit removed from this point, the researchers envision a future in which portable devices with different nanopores can sense a range of metabolites, proteins, and small molecules, or even do biomolecular sequencing.


Funding and Collaborations

The paper, “Sculpting conducting nanopore size and shape through de novo protein design,” appears in the July 19 edition of Science. The research team included scientists from the VUB-VIB Center for Structural Biology, UW Medicine, University of Virginia School of Medicine, University of Leeds, and University of Basel. Computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Research Foundation - Flanders (FWO) and the Flemish Government. The research team was funded by an FWO-EOS grant.


Sculpting conducting nanopore size and shape through de novo protein design. Berhanu, Majumder, Müntener, Whitehouse, et al. Science, 2024.

DOI: 10.1126/science.adn3796


Joran Lauwers

Joran Lauwers

Press Contact, VIB

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be